NeuroOne Medical Technologies Corp (NAS:NMTC)

Preliminary Q1 2025 Neuroone Medical Technologies Corp Earnings Call Transcript

Jan 10, 2025 / 04:00 PM GMT

Release Date Price: $6.79 (+4.74%)

Transcript 8-K

Key Points

Positve

NeuroOne Medical Technologies Corp (NMTC) has three FDA 510(k) cleared electrode families, showcasing regulatory success.
The company has exclusive partnerships with prestigious organizations like the Mayo Clinic and Zimmer Biomet, enhancing credibility and market reach.
The one RF ablation system is the first combination diagnostic and therapeutic system cleared by the FDA, potentially reducing hospitalizations and procedures.
Preliminary fiscal Q1 2025 revenues were reported at $6.2 million, with a significant portion from product revenues.
The company has no outstanding debt, providing financial stability and flexibility for future growth.

Negative

The full launch of the one RF system by Zimmer Biomet is still pending, with training expected to take another 3-4 months.
There is uncertainty regarding the quarterly product demand from Zimmer, affecting revenue predictability.
The company relies heavily on partnerships for commercialization, which may limit control over market penetration.
The revenue guidance does not account for the $3 million collaboration revenue, potentially skewing financial expectations.
The market for some of NeuroOne's target applications, like drug delivery, is still under development, posing future market entry risks.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NMTC.OQ - Neuroone Medical Technologies Corp
Preliminary Q1 2025 Neuroone Medical Technologies Corp Earnings Call
Jan 10, 2025 / 04:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to Neura One Medical Technology virtual investor webinar. At this time, all participants are on a listen-only mode, a question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr David Rosa. Thank you. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thanks, Rob. First and

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.